These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32212263)

  • 1. Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation.
    Armenian SH; Iukuridze A; Teh JB; Mascarenhas K; Herrera A; McCune JS; Zain JM; Mostoufi-Moab S; McCormack S; Slavin TP; Scott JM; Jones LW; Sun CL; Forman SJ; Wong FL; Nakamura R
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):962-972. PubMed ID: 32212263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
    DeFilipp Z; Troschel FM; Qualls DA; Li S; Kuklinski MW; Kempner ME; Hochberg E; Chen YB; El-Jawahri A; Fintelmann FJ
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1741-1747. PubMed ID: 29496561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
    Kharfan-Dabaja MA; Al Malki MM; Deotare U; Raj RV; El-Jurdi N; Majhail N; Cherry MA; Bashir Q; Darrah J; Nishihori T; Sibai H; Hamadani M; de Lima M; Gerds AT; Selby G; Qazilbash MH; Forman SJ; Ayala E; Lipton JH; Hari PN; Muzzafar T; Zhang L; Olteanu H; Perkins J; Sokol L; Kumar A; Ahmed S
    Br J Haematol; 2017 Dec; 179(5):781-789. PubMed ID: 28980314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma.
    Jaglowski SM; Ruppert AS; Hofmeister CC; Elder P; Blum W; Klisovic R; Vasu S; Penza S; Efebera YA; Benson DM; Devine SM; Andritsos LA
    Bone Marrow Transplant; 2014 Oct; 49(10):1323-9. PubMed ID: 25068419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation.
    Armenian SH; Xiao M; Berano Teh J; Lee B; Chang HA; Mascarenhas K; Lee S; Iukuridze A; Xie JJ; Scott JM; Jones LW; Lennie Wong F; Forman SJ; Nakamura R
    J Natl Cancer Inst; 2019 Aug; 111(8):837-844. PubMed ID: 30951603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse of Hodgkin lymphoma after autologous transplantation: Time to rethink treatment?
    Jethava Y; Guru Murthy GS; Hamadani M
    Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):47-56. PubMed ID: 28183681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
    Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
    Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation.
    Jabbour J; Manana B; Zahreddine A; Saade C; Charafeddine M; Bazarbachi A; Blaise D; El-Cheikh J
    Curr Res Transl Med; 2019 Aug; 67(3):93-99. PubMed ID: 30583985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.
    Hamadani M; Hari PN; Zhang Y; Carreras J; Akpek G; Aljurf MD; Ayala E; Bachanova V; Chen AI; Chen YB; Costa LJ; Fenske TS; Freytes CO; Ganguly S; Hertzberg MS; Holmberg LA; Inwards DJ; Kamble RT; Kanfer EJ; Lazarus HM; Marks DI; Nishihori T; Olsson R; Reddy NM; Rizzieri DA; Savani BN; Solh M; Vose JM; Wirk B; Maloney DG; Smith SM; Montoto S; Saber W; Alpdogan O; Cashen A; Dandoy C; Finke R; Gale R; Gibson J; Hsu JW; Janakiraman N; Laughlin MJ; Lill M; Cairo MS; Munker R; Rowlings PA; Schouten HC; Shea TC; Stiff PJ; Waller EK
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1729-36. PubMed ID: 25008330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
    Berro M; Arbelbide JA; Rivas MM; Basquiera AL; Ferini G; Vitriu A; Foncuberta C; Fernandez Escobar N; Requejo A; Milovic V; Yantorno S; Szelagoswki M; Martinez Rolon J; Bentolila G; Garcia JJ; Garcia P; Caeiro G; Castro M; Jaimovich G; Palmer S; Trucco JI; Bet LA; Shaw BE; Kusminsky GD
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1646-1650. PubMed ID: 28669923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation.
    Wu S; Rhee JW; Iukuridze A; Bosworth A; Chen S; Atencio L; Manubolu V; Bhandari R; Jamal F; Mei M; Herrera A; Rodriguez F; Forman S; Nakamura R; Wong FL; Budoff M; Armenian SH
    Cancer; 2024 Jun; 130(12):2205-2214. PubMed ID: 38358333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.
    Sumransub N; Cao Q; Juckett M; Betts B; Holtan S; Jurdi NE; Hu M; Allred J; Assi R; Maakaron JE
    Transplant Cell Ther; 2023 Apr; 29(4):263.e1-263.e7. PubMed ID: 36682471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
    Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of comorbidity on survival and collected CD34 + cell counts in autologous hematopoietic stem cell transplant patients.
    Sarıcı A; Erkurt MA; Kuku İ; Bahçecioğlu ÖF; Biçim S; Kaya E; Berber İ; Keser MF; Gök S; Özgül M
    Transfus Apher Sci; 2022 Feb; 61(1):103296. PubMed ID: 34696982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
    Tomblyn MR; Ewell M; Bredeson C; Kahl BS; Goodman SA; Horowitz MM; Vose JM; Negrin RS; Laport GG
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1051-7. PubMed ID: 21073974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
    Smith SM; Godfrey J; Ahn KW; DiGilio A; Ahmed S; Agrawal V; Bachanova V; Bacher U; Bashey A; Bolaños-Meade J; Cairo M; Chen A; Chhabra S; Copelan E; Dahi PB; Aljurf M; Farooq U; Ganguly S; Hertzberg M; Holmberg L; Inwards D; Kanate AS; Karmali R; Kenkre VP; Kharfan-Dabaja MA; Klein A; Lazarus HM; Mei M; Mussetti A; Nishihori T; Ramakrishnan Geethakumari P; Saad A; Savani BN; Schouten HC; Shah N; Urbano-Ispizua A; Vij R; Vose J; Sureda A; Hamadani M
    Cancer; 2018 Jun; 124(12):2541-2551. PubMed ID: 29645093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of body mass index on pulmonary complications in patients with non-Hodgkin lymphoma treated with hematopoietic stem cell transplant.
    Lin C; Lin J; Stavas M; Li S; Canady KJ; Romberger DJ; Loberiza FR
    Leuk Lymphoma; 2015; 56(11):3058-64. PubMed ID: 25739939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation.
    Kapke JT; Epperla N; Shah N; Richardson K; Carrum G; Hari PN; Pingali SR; Hamadani M; Karmali R; Fenske TS
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):408-414. PubMed ID: 28756899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.
    Navarro WH; Agovi MA; Logan BR; Ballen K; Bolwell BJ; Frangoul H; Gupta V; Hahn T; Ho VT; Juckett M; Lazarus HM; Litzow MR; Liesveld JL; Moreb JS; Marks DI; McCarthy PL; Pasquini MC; Rizzo JD
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1442-50. PubMed ID: 20412867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.